CIK 0001417926 · Non-accelerated filer<br>Smaller reporting company
INVO Fertility, Inc.
Sign in to watch- Ticker
- IVF
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 204036208
- Phone
- (978) 878-9505
- Business address
- 5582 BROADCAST COURT, SARASOTA, FL, 34240
- Former names
- NAYA Biosciences, Inc., INVO Bioscience, Inc., EMY'S SALSA AJI DISTRIBUTION COMPANY, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-04 | Szot Matthew K Director | Other disposition | −3 | 0 | ||
| 2025-12-03 | Szot Matthew K Director | Sale | −4 | $1.52 | $6 | 3 |
| 2025-08-26 | Shum Steve Chief Executive Officer | Grant or award · Stock Option (right to buy) | +42,000 | 42,451 | ||
| 2025-08-26 | Szot Matthew K Director | Grant or award · Stock Option (right to buy) | +45,000 | 45,164 | ||
| 2025-08-26 | Ryan Barbara Director | Grant or award · Stock Option (right to buy) | +45,000 | 45,157 | ||
| 2025-08-26 | Messina Rebecca Director | Grant or award · Stock Option (right to buy) | +45,000 | 45,143 | ||
| 2025-08-26 | Goren Andrea Chief Financial Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,409 | ||
| 2025-08-26 | DAVIS TRENT D Director | Grant or award · Stock Option (right to buy) | +45,000 | 45,159 | ||
| 2023-05-18 | Szot Matthew K Director | Grant or award · Stock Option (right to buy) | +85,000 | 85,000 | ||
| 2023-05-18 | Shum Steve Chief Executive Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2023-05-18 | Ryan Barbara Director | Grant or award · Stock Option (right to buy) | +85,000 | 85,000 | ||
| 2023-05-18 | Messina Rebecca Director | Grant or award · Stock Option (right to buy) | −85,000 | 85,000 | ||
| 2023-05-18 | Goren Andrea Chief Financial Officer | Grant or award · Stock option (right to buy) | +81,000 | 81,000 | ||
| 2023-05-18 | DAVIS TRENT D Director | Grant or award · Stock Option (right to buy) | +85,000 | 85,000 | ||
| 2023-05-18 | Campbell Michael Jos. Chief Operating Officer | Grant or award · Stock Option (right to buy) | +83,000 | 83,000 | ||
| 2022-06-01 | Shum Steve Chief Executive Officer | Purchase | +58,885 | $0.95 | $56K | 128,420 |
| 2022-06-01 | Ryan Barbara Director | Purchase | +10,526 | $0.95 | $10K | 22,991 |
| 2022-06-01 | DAVIS TRENT D Director | Purchase | +11,184 | $0.95 | $11K | 33,622 |
| 2022-06-01 | Szot Matthew K Director | Purchase | +14,474 | $0.95 | $14K | 39,175 |
| 2022-06-01 | Segal Jeffrey Director | Purchase | +9,211 | $0.95 | $9K | 28,220 |
Page 1 of 8 · 154 trades